|
US6451784B1
(en)
*
|
1996-12-30 |
2002-09-17 |
Battellepharma, Inc. |
Formulation and method for treating neoplasms by inhalation
|
|
AU1200100A
(en)
*
|
1998-10-02 |
2000-04-26 |
Battelle Memorial Institute |
Inhalation chemotherapy for prevention and treatment of metastatic tumors in thelung
|
|
AU2986800A
(en)
*
|
1999-02-08 |
2000-08-25 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Methods of inhibiting the hgf-met-upa-plasmin network
|
|
US7311924B2
(en)
*
|
1999-04-01 |
2007-12-25 |
Hana Biosciences, Inc. |
Compositions and methods for treating cancer
|
|
GB9920548D0
(en)
*
|
1999-08-31 |
1999-11-03 |
Rhone Poulenc Rorer Sa |
Treatment of hepatocellular carcinoma
|
|
US6651655B1
(en)
*
|
2000-01-18 |
2003-11-25 |
Quadrant Technologies Limited |
Inhaled vaccines
|
|
ES2328446T5
(es)
|
2000-02-04 |
2014-02-27 |
Children's Hospital Research Foundation |
Uso de lipasa ácida lisosomal para tratar la aterosclerosis y enfermedades asociadas
|
|
EP1280576B1
(en)
*
|
2000-04-03 |
2010-05-05 |
Battelle Memorial Institute |
Dispensing devices and liquid formulations
|
|
US8071740B2
(en)
|
2000-11-17 |
2011-12-06 |
Vascular Biogenics Ltd. |
Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
|
|
AU2003222427B8
(en)
*
|
2000-11-17 |
2010-04-29 |
Vascular Biogenics Ltd. |
Promoters exhibiting endothelial cell specificity and methods of using same
|
|
US20070286845A1
(en)
*
|
2000-11-17 |
2007-12-13 |
Vascular Biogenics Ltd. |
Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
|
|
US8039261B2
(en)
*
|
2000-11-17 |
2011-10-18 |
Vascular Biogenics Ltd. |
Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
|
|
US20100282634A1
(en)
*
|
2000-11-17 |
2010-11-11 |
Dror Harats |
Promoters Exhibiting Endothelial Cell Specificity and Methods of Using Same for Regulation of Angiogenesis
|
|
US6838452B2
(en)
*
|
2000-11-24 |
2005-01-04 |
Vascular Biogenics Ltd. |
Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
|
|
AU3664102A
(en)
*
|
2000-12-01 |
2002-06-11 |
Battelle Memorial Institute |
Method for stabilizing biomolecules in liquid formulations
|
|
EP1401875A4
(en)
*
|
2001-05-04 |
2005-01-26 |
Univ Utah Res Found |
HYALURONIC ACID-CONTAINING BIOKON JUGATES: TARGETED DELIVERY OF ANTIBODIES TO CANCER CELLS
|
|
US7458374B2
(en)
|
2002-05-13 |
2008-12-02 |
Alexza Pharmaceuticals, Inc. |
Method and apparatus for vaporizing a compound
|
|
US7585493B2
(en)
|
2001-05-24 |
2009-09-08 |
Alexza Pharmaceuticals, Inc. |
Thin-film drug delivery article and method of use
|
|
US7090830B2
(en)
|
2001-05-24 |
2006-08-15 |
Alexza Pharmaceuticals, Inc. |
Drug condensation aerosols and kits
|
|
US20070122353A1
(en)
|
2001-05-24 |
2007-05-31 |
Hale Ron L |
Drug condensation aerosols and kits
|
|
US7766013B2
(en)
|
2001-06-05 |
2010-08-03 |
Alexza Pharmaceuticals, Inc. |
Aerosol generating method and device
|
|
JP2005502653A
(ja)
*
|
2001-08-20 |
2005-01-27 |
トランセーヴ・インコーポレーテッド |
肺ガンの治療方法
|
|
CA2457148A1
(en)
*
|
2001-08-20 |
2003-02-27 |
Transave, Inc. |
Treatment of cancers by inhalation of stable platinum-containing formulations
|
|
WO2003032906A2
(en)
*
|
2001-10-15 |
2003-04-24 |
Crititech, Inc. |
Delivery of poorly soluble drugs
|
|
CA2463816C
(en)
|
2001-10-19 |
2014-07-08 |
Vascular Biogenics Ltd. |
Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
|
|
EP1472230B1
(en)
*
|
2002-02-08 |
2009-06-17 |
Conforma Therapeutic Corporation |
Ansamycins having improved pharmacological and biological properties
|
|
WO2003075889A1
(en)
*
|
2002-03-05 |
2003-09-18 |
Transave, Inc. |
An inhalation system for prevention and treatment of intracellular infections
|
|
ITPI20020018A1
(it)
*
|
2002-03-28 |
2002-06-26 |
Azienda Ospedaliera Pisana |
Ventilazione polmonare a variazione di flusso
|
|
GB0208516D0
(en)
*
|
2002-04-15 |
2002-05-22 |
Univ Liverpool |
Chemotherapy
|
|
US20050169883A1
(en)
*
|
2002-05-06 |
2005-08-04 |
Prestwich Glenn D. |
Preblocking with non-ha gags increases effectiveness of ha conjugated anticancer agents
|
|
US7677411B2
(en)
*
|
2002-05-10 |
2010-03-16 |
Oriel Therapeutics, Inc. |
Apparatus, systems and related methods for processing, dispensing and/or evaluatingl dry powders
|
|
US6889690B2
(en)
*
|
2002-05-10 |
2005-05-10 |
Oriel Therapeutics, Inc. |
Dry powder inhalers, related blister devices, and associated methods of dispensing dry powder substances and fabricating blister packages
|
|
US6985798B2
(en)
|
2002-05-10 |
2006-01-10 |
Oriel Therapeutics, Inc. |
Dry powder dose filling systems and related methods
|
|
US7118010B2
(en)
|
2002-05-10 |
2006-10-10 |
Oriel Therapeutics, Inc. |
Apparatus, systems and related methods for dispensing and /or evaluating dry powders
|
|
EP1534366B1
(en)
*
|
2002-06-27 |
2014-01-08 |
Oriel Therapeutics, Inc. |
Dry powder dose filling systems and related methods
|
|
JP2006502233A
(ja)
*
|
2002-08-02 |
2006-01-19 |
トランセーブ，インク． |
白金凝集物およびその製造方法
|
|
US9186322B2
(en)
|
2002-08-02 |
2015-11-17 |
Insmed Incorporated |
Platinum aggregates and process for producing the same
|
|
US7718189B2
(en)
|
2002-10-29 |
2010-05-18 |
Transave, Inc. |
Sustained release of antiinfectives
|
|
EP1581236B1
(en)
*
|
2002-10-29 |
2013-10-16 |
Insmed Incorporated |
Sustained release of antiinfectives
|
|
US7879351B2
(en)
*
|
2002-10-29 |
2011-02-01 |
Transave, Inc. |
High delivery rates for lipid based drug formulations, and methods of treatment thereof
|
|
US20060179491A1
(en)
*
|
2002-11-12 |
2006-08-10 |
Brian Graham |
Process for treating non-human animals
|
|
US7353533B2
(en)
|
2002-12-18 |
2008-04-01 |
Novell, Inc. |
Administration of protection of data accessible by a mobile device
|
|
US7185650B2
(en)
*
|
2002-12-19 |
2007-03-06 |
Arie Huber |
Systems and methods for determining a minimum effective dose of an inhaled drug for an individual patient at a given time
|
|
US20060148776A1
(en)
*
|
2003-03-13 |
2006-07-06 |
Conforma Therapeutics Corporation |
Drug formulations having long and medium chain triglycerides
|
|
US20040187864A1
(en)
*
|
2003-03-24 |
2004-09-30 |
Cindet, Llc |
Inhalation device and method
|
|
EP1625333A1
(en)
|
2003-05-21 |
2006-02-15 |
Alexza Pharmaceuticals, Inc. |
Self-contained heating unit and drug-supply unit employing same
|
|
PL1670514T3
(pl)
*
|
2003-09-25 |
2010-11-30 |
Astellas Pharma Inc |
Środek przeciwnowotworowy zawierający inhibitor deacetylazy histonowej i inhibitor topoizomerazy II
|
|
US7377277B2
(en)
*
|
2003-10-27 |
2008-05-27 |
Oriel Therapeutics, Inc. |
Blister packages with frames and associated methods of fabricating dry powder drug containment systems
|
|
US7451761B2
(en)
*
|
2003-10-27 |
2008-11-18 |
Oriel Therapeutics, Inc. |
Dry powder inhalers, related blister package indexing and opening mechanisms, and associated methods of dispensing dry powder substances
|
|
WO2005089448A2
(en)
*
|
2004-03-18 |
2005-09-29 |
Transave, Inc. |
Administration of cisplatin by inhalation
|
|
CN101001633A
(zh)
*
|
2004-05-21 |
2007-07-18 |
特兰萨夫公司 |
肺病和肺病前期病症的治疗
|
|
US7540286B2
(en)
|
2004-06-03 |
2009-06-02 |
Alexza Pharmaceuticals, Inc. |
Multiple dose condensation aerosol devices and methods of forming condensation aerosols
|
|
EP2246086A3
(en)
|
2004-08-12 |
2012-11-21 |
Alexza Pharmaceuticals, Inc. |
Aerosol drug delivery device incorporating percussively activated heating unit
|
|
US20060045849A1
(en)
*
|
2004-08-24 |
2006-03-02 |
Farhan Taghizadeh |
Method of customizing the fragrance of nasal medications
|
|
US20060246124A1
(en)
*
|
2004-11-08 |
2006-11-02 |
Pilkiewicz Frank G |
Methods of treating cancer with lipid-based platinum compound formulations administered intraperitoneally
|
|
BRPI0608661A2
(pt)
*
|
2005-04-07 |
2010-01-19 |
Conforma Therapeutics Corp |
formulaÇço farmacÊutica, uso de formulaÇço farmacÊutica, e, mÉtodo de preparaÇço de uma formulaÇço farmacÊutica
|
|
US20060283742A1
(en)
*
|
2005-06-16 |
2006-12-21 |
Canel Lightning Co. Ltd. |
Multi-lamp display packaging for lamps with collapsible lampshades
|
|
US20090180964A1
(en)
*
|
2005-06-24 |
2009-07-16 |
Rao Papineni |
Transmucosal delivery of optical, spect, multimodal,drug or biological cargo laden nanoparticle(s) in small animals or humans
|
|
WO2007056264A2
(en)
*
|
2005-11-08 |
2007-05-18 |
Transave, Inc. |
Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
|
|
US9107824B2
(en)
|
2005-11-08 |
2015-08-18 |
Insmed Incorporated |
Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
|
|
WO2007056263A2
(en)
*
|
2005-11-08 |
2007-05-18 |
Transave, Inc. |
Methods of treating cancer with high potency lipid-based platinum compound formulations administered intravenously
|
|
US20070190181A1
(en)
*
|
2005-11-08 |
2007-08-16 |
Pilkiewicz Frank G |
Methods of treating cancer with lipid-based platinum compound forumulations administered intravenously
|
|
US20070122350A1
(en)
*
|
2005-11-30 |
2007-05-31 |
Transave, Inc. |
Safe and effective methods of administering therapeutic agents
|
|
JP2009518302A
(ja)
*
|
2005-12-01 |
2009-05-07 |
コンフォーマ・セラピューティクス・コーポレイション |
アンサマイシン含有組成物
|
|
HUE029994T2
(en)
|
2005-12-08 |
2017-04-28 |
Insmed Inc |
Lipid-based compositions of antiinfectives for treating pulmonary infections
|
|
GB0526552D0
(en)
|
2005-12-29 |
2006-02-08 |
Morvus Technology Ltd |
New use
|
|
US20080045589A1
(en)
*
|
2006-05-26 |
2008-02-21 |
Susan Kelley |
Drug Combinations with Substituted Diaryl Ureas for the Treatment of Cancer
|
|
US11759477B2
(en)
|
2007-02-26 |
2023-09-19 |
Heartbeet Ltd. |
Compositions of nitrates and methods of use thereof
|
|
US10842813B2
(en)
|
2007-02-26 |
2020-11-24 |
Heartbeet Ltd |
Compositions of nitrates and methods of use thereof
|
|
US10821132B2
(en)
|
2007-02-26 |
2020-11-03 |
Heartbeet Ltd |
Compositions of nitrates and methods of use thereof
|
|
DK2124638T3
(en)
|
2007-02-26 |
2017-03-20 |
Heartbeet Ltd |
COMPOSITION INCREASING PERFORMANCE AND USING IT
|
|
EP2121088B1
(en)
|
2007-03-09 |
2016-07-13 |
Alexza Pharmaceuticals, Inc. |
Heating unit for use in a drug delivery device
|
|
WO2008134630A1
(en)
*
|
2007-04-30 |
2008-11-06 |
Apt Pharmaceuticals |
Dexrazoxane compounds for cardioprotection
|
|
US20080275036A1
(en)
*
|
2007-05-02 |
2008-11-06 |
Apt Pharmaceuticals, Inc. |
Prevention and treatment of cardiac conditions
|
|
WO2008137717A1
(en)
*
|
2007-05-04 |
2008-11-13 |
Transave, Inc. |
Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods and uses thereof
|
|
US9114081B2
(en)
|
2007-05-07 |
2015-08-25 |
Insmed Incorporated |
Methods of treating pulmonary disorders with liposomal amikacin formulations
|
|
US9119783B2
(en)
|
2007-05-07 |
2015-09-01 |
Insmed Incorporated |
Method of treating pulmonary disorders with liposomal amikacin formulations
|
|
US9333214B2
(en)
|
2007-05-07 |
2016-05-10 |
Insmed Incorporated |
Method for treating pulmonary disorders with liposomal amikacin formulations
|
|
JP5570996B2
(ja)
|
2007-12-14 |
2014-08-13 |
エアロデザインズ インコーポレイテッド |
エアロゾル化可能な食料品の送達
|
|
BRPI0920655A2
(pt)
*
|
2008-10-07 |
2019-07-09 |
Rexahn Pharmaceuticals, Inc. |
conjugados e hpma-docetaxel ou gencitabina e usos dos mesmos
|
|
KR101721865B1
(ko)
|
2009-10-13 |
2017-04-03 |
렉산 파마슈티컬스, 인코포레이티드 |
항암제의 전달을 위한 폴리머 시스템
|
|
MX369828B
(es)
|
2012-05-21 |
2019-11-22 |
Insmed Inc |
Sistemas para tratar infecciones pulmonares.
|
|
CN121606602A
(zh)
|
2012-09-04 |
2026-03-06 |
埃莱森制药股份有限公司 |
用顺铂脂质复合物预防癌症的肺部复发
|
|
US9801874B2
(en)
|
2012-11-20 |
2017-10-31 |
Spectrum Pharmaceuticals |
Method for the preparation of liposome encapsulated vincristine for therapeutic use
|
|
RU2018135921A
(ru)
|
2012-11-29 |
2019-02-05 |
Инсмед Инкорпорейтед |
Стабилизированные составы ванкомицина
|
|
EP3915369A1
(en)
|
2012-12-13 |
2021-12-01 |
CytRx Corporation |
Anthracycline formulations
|
|
CN113842392A
(zh)
|
2013-06-05 |
2021-12-28 |
西特克斯公司 |
用于治疗癌症的细胞毒素剂
|
|
US20160022720A1
(en)
*
|
2013-08-02 |
2016-01-28 |
Children's Hospital Medical Center |
Compositions and methods for treating disease states associated with activated t cells and/or b cells
|
|
US10307370B2
(en)
|
2013-10-08 |
2019-06-04 |
AI Therapeutics, Inc. |
Rapamycin for the treatment of lymphangioleiomyomatosis
|
|
KR20160120739A
(ko)
|
2014-02-11 |
2016-10-18 |
램 테라퓨틱스, 인코포레이티드 |
림프관평활근종증의 치료를 위한 라파마이신
|
|
US10307371B2
(en)
|
2014-02-11 |
2019-06-04 |
AI Therapeutics, Inc. |
Rapamycin for the treatment of lymphangioleiomyomatosis
|
|
DK3125875T3
(da)
|
2014-04-04 |
2023-07-24 |
Ai Therapeutics Inc |
Inhalerbar rapamycinformulering til behandling af aldersrelaterede tilstande
|
|
TWI601542B
(zh)
|
2014-04-18 |
2017-10-11 |
林信湧 |
一種用於治療肺癌之吸入式醫藥組成物及其備製方法
|
|
US10874355B2
(en)
|
2014-04-24 |
2020-12-29 |
Cognoa, Inc. |
Methods and apparatus to determine developmental progress with artificial intelligence and user input
|
|
SMT202000516T1
(it)
|
2014-05-15 |
2020-11-10 |
Insmed Inc |
Metodi per trattamento di infezioni micobatteriche polmonati non tubercolari
|
|
KR20170095807A
(ko)
|
2014-10-07 |
2017-08-23 |
램 테라퓨틱스, 인코포레이티드 |
폐 고혈압의 치료를 위한 흡입가능 라파마이신 제제
|
|
MA40910A
(fr)
|
2014-11-07 |
2017-09-12 |
Civitas Therapeutics Inc |
Poudres de rapamycine pour administration pulmonaire
|
|
WO2016130645A1
(en)
|
2015-02-10 |
2016-08-18 |
Lam Therapeutics, Inc. |
Rapamycin for the treatment of lymphangioleiomyomatosis
|
|
EP3302423B1
(en)
|
2015-06-04 |
2022-05-25 |
Crititech, Inc. |
Particle production system and particle collection device
|
|
TWI678213B
(zh)
|
2015-07-22 |
2019-12-01 |
美商史倍壯製藥公司 |
用於長春新鹼硫酸鹽脂質體注射之即可使用的調配物
|
|
US11972336B2
(en)
|
2015-12-18 |
2024-04-30 |
Cognoa, Inc. |
Machine learning platform and system for data analysis
|
|
BR112018069628A2
(pt)
|
2016-04-04 |
2019-02-12 |
Crititech, Inc. |
métodos para tratamento de tumor sólido
|
|
CN118609834A
(zh)
|
2016-11-14 |
2024-09-06 |
科格诺亚公司 |
用于评估发育状况并提供覆盖度和可靠性控制的方法和装置
|
|
US10874768B2
(en)
*
|
2017-01-20 |
2020-12-29 |
Covidien Lp |
Drug eluting medical device
|
|
CA3053245A1
(en)
*
|
2017-02-09 |
2018-08-16 |
Cognoa, Inc. |
Platform and system for digital personalized medicine
|
|
US20220254461A1
(en)
*
|
2017-02-09 |
2022-08-11 |
Cognoa, Inc. |
Machine learning algorithms for data analysis and classification
|
|
EP3615145B1
(en)
|
2017-06-09 |
2024-05-15 |
Crititech, Inc. |
Compositions for use in the treatment of epithelial cysts by intracystic injection of antineoplastic particles
|
|
WO2018231908A1
(en)
*
|
2017-06-14 |
2018-12-20 |
Crititech, Inc. |
Methods for treating lung disorders
|
|
US10894019B2
(en)
|
2017-08-15 |
2021-01-19 |
University Of South Carolina |
Drug delivery system and method for targeting cancer stem cells
|
|
KR20250057947A
(ko)
|
2017-10-03 |
2025-04-29 |
크리티테크, 인크. |
암의 치료를 위한 면역치료제의 전신 전달과 조합된 항신생물성 입자의 국소 전달
|
|
EP3746138B1
(en)
|
2018-02-02 |
2025-12-10 |
Alexza Pharmaceuticals, Inc. |
Electrical condensation aerosol device
|
|
EP3773505B1
(en)
|
2018-03-30 |
2026-04-29 |
Insmed Incorporated |
Methods for continuous manufacture of liposomal drug products
|
|
WO2019213398A1
(en)
|
2018-05-02 |
2019-11-07 |
Insmed Incorporated |
Methods for the manufacture of liposomal drug formulations
|
|
CA3134521A1
(en)
|
2019-03-22 |
2020-10-01 |
Cognoa, Inc. |
Personalized digital therapy methods and devices
|
|
US11672767B2
(en)
|
2019-05-13 |
2023-06-13 |
University Of South Carolina |
Enzymatically cleavable self-assembled nanoparticles for morphogen delivery
|
|
WO2021040673A1
(en)
*
|
2019-08-26 |
2021-03-04 |
Alain Martin |
Methods for the treatment of chronic hypoxemia and inhibiting lung fibrosis in patients with pulmonary fibrosis with and without copd
|
|
CN111067879B
(zh)
*
|
2020-01-20 |
2022-08-09 |
珠海瑞思普利医药科技有限公司 |
一种抗肿瘤组合物吸入粉雾剂及其制备方法
|
|
US20240120050A1
(en)
*
|
2022-10-07 |
2024-04-11 |
Insight Direct Usa, Inc. |
Machine learning method for predicting a health outcome of a patient using video and audio analytics
|